These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18250232)

  • 21. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Socioeconomic status, drug insurance benefits, and new prescriptions for inhaled corticosteroids in schoolchildren with asthma.
    Kozyrskyj AL; Mustard CA; Simons FE
    Arch Pediatr Adolesc Med; 2001 Nov; 155(11):1219-24. PubMed ID: 11695930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
    Campbell JD; Allen-Ramey F; Sajjan SG; Maiese EM; Sullivan SD
    Am J Manag Care; 2011 Oct; 17(10):703-10. PubMed ID: 22106463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
    Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
    Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seasonal patterns of Asthma medication fills among diverse populations of the United States.
    Turi KN; Gebretsadik T; Lee RL; Hartert TV; Evans AM; Stone C; Sicignano NM; Wu AC; Iribarren C; Butler MG; Mitchel E; Morrow J; Larkin EK; Wu P
    J Asthma; 2018 Jul; 55(7):764-770. PubMed ID: 28881155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada.
    Zhang T; Smith MA; Camp PG; Carleton BC
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):744-51. PubMed ID: 23559540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of risk factors and health outcomes among persons with asthma.
    Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
    J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.
    Hodgkin D; Horgan CM; Creedon TB; Merrick EL; Stewart MT
    J Ment Health Policy Econ; 2015 Dec; 18(4):165-73. PubMed ID: 26729008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Inhaled Corticosteroid Use and Bone Fracture in Children With Asthma.
    Gray N; Howard A; Zhu J; Feldman LY; To T
    JAMA Pediatr; 2018 Jan; 172(1):57-64. PubMed ID: 29131874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.
    Wu AC; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Butler MG; Miroshnik I; Rusinak D; Davis RL; Hartert T; Weiss ST; Lieu TA
    J Allergy Clin Immunol Pract; 2014; 2(5):607-13. PubMed ID: 25213056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.
    Dusetzina SB; Huskamp HA; Winn AN; Basch E; Keating NL
    JAMA Oncol; 2018 Jun; 4(6):e173598. PubMed ID: 29121177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
    Allen-Ramey FC; Duong PT; Riedel AA; Markson LE; Weiss KB
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid program.
    Keast SL; Thompson D; Farmer K; Smith M; Nesser N; Harrison D
    J Manag Care Spec Pharm; 2014 Jun; 20(6):612-21. PubMed ID: 24856599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
    Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S
    Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Financial barriers to care among low-income children with asthma: health care reform implications.
    Fung V; Graetz I; Galbraith A; Hamity C; Huang J; Vollmer WM; Hsu J; Wu AC
    JAMA Pediatr; 2014 Jul; 168(7):649-56. PubMed ID: 24840805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalation.
    Sullivan PW; Campbell JD; Ghushchyan VH; Globe G; Lange J; Woolley JM
    J Asthma; 2015 Sep; 52(7):669-80. PubMed ID: 25731600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Chauhan BF; Ducharme FM
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.
    Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
    Cochrane Database Syst Rev; 2010 Apr; (4):CD005533. PubMed ID: 20393943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.